Dartmouth College

Dartmouth Digital Commons
Dartmouth Scholarship

Faculty Work

3-3-2015

Spectral Gene Set Enrichment (SGSE)
H Robert Frost
Dartmouth College

Zhigang Li
Dartmouth College

Jason H. Moore
Dartmouth College

Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Bioinformatics Commons, Biostatistics Commons, Genetics and Genomics Commons, and
the Medicine and Health Sciences Commons

Dartmouth Digital Commons Citation
Frost, H Robert; Li, Zhigang; and Moore, Jason H., "Spectral Gene Set Enrichment (SGSE)" (2015).
Dartmouth Scholarship. 565.
https://digitalcommons.dartmouth.edu/facoa/565

This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has
been accepted for inclusion in Dartmouth Scholarship by an authorized administrator of Dartmouth Digital
Commons. For more information, please contact dartmouthdigitalcommons@groups.dartmouth.edu.

Frost et al. BMC Bioinformatics (2015) 16:70
DOI 10.1186/s12859-015-0490-7

METHODOLOGY ARTICLE

Open Access

Spectral gene set enrichment (SGSE)
H Robert Frost1,2,3* , Zhigang Li1,2 and Jason H Moore1,2,3

Abstract
Background: Gene set testing is typically performed in a supervised context to quantify the association between
groups of genes and a clinical phenotype. In many cases, however, a gene set-based interpretation of genomic data is
desired in the absence of a phenotype variable. Although methods exist for unsupervised gene set testing, they
predominantly compute enrichment relative to clusters of the genomic variables with performance strongly
dependent on the clustering algorithm and number of clusters.
Results: We propose a novel method, spectral gene set enrichment (SGSE), for unsupervised competitive testing of
the association between gene sets and empirical data sources. SGSE first computes the statistical association between
gene sets and principal components (PCs) using our principal component gene set enrichment (PCGSE) method. The
overall statistical association between each gene set and the spectral structure of the data is then computed by
combining the PC-level p-values using the weighted Z-method with weights set to the PC variance scaled by
Tracy-Widom test p-values. Using simulated data, we show that the SGSE algorithm can accurately recover spectral
features from noisy data. To illustrate the utility of our method on real data, we demonstrate the superior performance
of the SGSE method relative to standard cluster-based techniques for testing the association between MSigDB gene
sets and the variance structure of microarray gene expression data.
Conclusions: Unsupervised gene set testing can provide important information about the biological signal held in
high-dimensional genomic data sets. Because it uses the association between gene sets and samples PCs to generate
a measure of unsupervised enrichment, the SGSE method is independent of cluster or network creation algorithms
and, most importantly, is able to utilize the statistical significance of PC eigenvalues to ignore elements of the data
most likely to represent noise.
Background
Gene set testing has become an indispensable tool for the
analysis and interpretation of high dimensional genomic
data, including measures of DNA sequence variation,
DNA methylation, RNA expression and protein abundance [1,2]. By focusing on the collective effect of biologically meaningful groups of genomic variables, rather
than just the marginal effect of individual variables, gene
set testing methods can significantly improve statistical
power, replication of results and biological interpretation. Because of these benefits, significant effort has been
devoted over the last decade to building large repositories of functional gene sets [3-5], creating methods for
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refining and customizing these gene set collections [6-8]
and developing effective statistical techniques for gene set
testing [9-13].
Gene set testing is normally used to quantify the association between functional groups of genomic variables
and a clinical phenotype, e.g., cancer case/control status. Many important use cases exist, however, where a
gene set-based interpretation of genomic data is desired
in the absence of a phenotype variable, e.g., case-only
data collections. For such unsupervised applications, the
standard approach for gene set testing involves the computation of the association between gene sets and a categorical variable defined by disjoint clusters of genomic
variables. Such methods typically compute the association between each gene set and the variable clustering
using either information theoretic measures [14,15] or
contingency table-based statistical tests which incorrectly
assume independence among the genomic variables
[16-18]. Although these techniques provide a measure of
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gene set enrichment for a given clustering of genomic
data, the motivation for most methods is cluster evaluation rather than unsupervised biological interpretation.
Cluster-based gene set enrichment results are strongly
dependent on the clustering method employed and the
number of computed clusters. This sensitivity to the clustering method and number of clusters makes these methods very useful for clustering evaluation but unreliable as
general measures of unsupervised gene set enrichment.
Specifically, since these methods advocate the use gene
set enrichment results to select the clustering method and
number of clusters, instead of often unreliable metrics
such as the gap statistic [19] or average silhouette width
[20], it is unclear what clustering method or number of
clusters should be used if the goal is unbiased gene set
testing.
An alternative approach for unsupervised gene set testing with many similarities to cluster-based methods is
gene set enrichment of gene networks. This approach
typically involves the computation of a network from
a genomic dataset with network nodes represented by
genomic variables, e.g., a co-expression network for gene
expression data [21], a community detection algorithm
is then used to decompose the network nodes into distinct groups and, finally, gene set testing is performed
relative to each community or all communities. If the network communities are treated like gene clusters, the same
information theoretic or contingency table-based methods employed for cluster-based enrichment can be used
to calculate the association between gene sets and network communities. Approaches have also been developed
that directly leverage the network structure to test for the
association between gene sets and single network nodes
[22] or groups of nodes [23]. Similar to cluster-based
approaches, gene set enrichment of networks is highly
dependent on the method used to build the network from
genomic data and algorithms employed for community
detection.
Methods have also been developed to test the association between gene sets and latent variables computed
from genomic data sets via techniques such as principal component analysis (PCA) or independent component analysis (ICA). Most of these methods test for the
association with just a single latent variable and employ
an anti-conservative contingency-table based test on a
dichotomized version of the loadings for the latent variable [24-26]. An exception is our recently developed principal component gene set enrichment (PCGSE) method
[27] that performs competitive gene set testing relative
to each PC using a statistical test that adjusts for correlation among gene set members. Similar to single cluster
gene set testing methods, methods that perform gene set
testing relative to a single latent variable can only provide an interpretation for a portion of a genomic data
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set. To test for the association between gene sets and a
collection of latent variables representative of the entire
data set, matrix correlation methods [28,29] have been
employed, however, such methods are dependent on the
number of latent variables included in the test and can
only be used for self-contained gene set testing [30] (Q2 in
the terminology of Tian et al. [31]).
Effective methods do not currently exist for unsupervised gene set testing against a competitive null hypothesis
that are independent of specific cluster analysis or network analysis approaches. To address this shortcoming,
we have developed spectral gene set enrichment (SGSE),
an approach for unsupervised competitive testing of the
association between gene sets and empirical data sources
independent of cluster or network analysis. The SGSE
method first computes the statistical association between
gene sets and principal components (PCs) using our principal component gene set enrichment (PCGSE) method.
The overall statistical association between each gene set
and the spectral structure of the data is then computed
by combining the PC-level p-values using the weighted
Z-method with weights set to the PC variance scaled
by lower-tailed p-value computed for the PC variance
according to the Tracy-Widom distribution. Although
described in the context of gene sets and genomic data,
the SGSE method can be used to compute the statistical association between any collection of variable groups
and the spectral structure of any empirical data set. To
facilitate use of the SGSE method by other researchers,
we have included an implementation of the algorithm in
the PCGSE R package, which is available from the CRAN
repository. Using simulated gene expression data and simulated gene sets, we show that the SGSE method can
accurately recover known spectral features from noisy
data, features that are undetectable using cluster-based
approaches. To illustrate the utility of our method on real
genomic data, we compare the performance of the SGSE
method and a cluster-based technique on testing the association between MSigDB gene sets and the spectra of two
cancer microarray gene expression data sets.

Methods
SGSE inputs

Similar to our principal component gene set enrichment
(PCGSE) method [27], the SGSE method takes as input
both an n × p genomic data matrix X quantifying p
genomic variables under n experimental conditions and
an f ×p binary annotation matrix A that specifies the association between the p genomic variables and f functional
categories.
The genomic data held in X, e.g., mRNA expression levels, will be modeled as a sample of n independent observations from a p-dimensional random vector
x. It is assumed that any desired transformations on
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X have been performed and that missing values have
been imputed or removed. Although the SGSE method
is robust to departures from multivariate normality, as
discussed in Section “PC statistical significance” below,
it will be assumed that x ∼ MVN(μ, ) with correlation matrix P. This distributional assumption is usually
well justified since sources of genomic data, especially
gene expression data, are typically well approximated
by a multivariate normal distribution after appropriate
transformations.
The rows of A represent f biological categories, e.g.,
KEGG pathways or GO categories, and the elements ai,j
hold indicator variables whose value depends on whether
an annotation exists between the function i and genomic
variable j.
SGSE algorithm

Enrichment of the gene sets defined by A relative to
the spectra of X is performed using the following steps,
which are explained in detail in sections “PCA for SGSE”
thru “Combined significance of PCGSE p-values” below.
1. Perform PCA on X.
2. Determine q, the number of PCs used to represent
the spectra of X.
3. For all q PCs, use the PCGSE method to compute the
statistical significance of the association between
each PC and each of the f gene sets defined by A
according to a competitive null hypothesis.
4. Compute the statistical significance of the
association between each of the f gene sets and the
spectra of X using the weighted Z-method on the q
PCGSE p-values with weights based on the PC
variances optionally scaled according to PC statistical
significance.
PCA for SGSE

Because PCs are not invariant under scaling of the data
[28], the PCA solution for SGSE is computed on a mean
centered and standardized version of X, X̃. The PC loading
vectors and variances of X̃ are thus the eigenvectors and
eigenvalues of:
S=

1
X̃T X̃
n−1

(1)

The spectral decomposition of S is defined as:
r

S=

X̃


λi vi vTi

order: λ1 ≥ λ2 ≥ . . . ≥ λrX̃ . Because x ∼ MVN, (n − 1)S
is approximately Wishart distributed:
(n − 1)S = X̃T X̃ ∼ W (n, P)

Similar to PCGSE, the PCA solution for SGSE is realized via the singular value decomposition (SVD) of a,
X̃ = UEVT , where the columns of V represent the PC
loading vectors, the entries in the diagonal matrix E are
proportional to the square roots of the PC variances and
the columns of UE are the PCs.
PC statistical significance

Random matrix theory (RMT) methods provide useful
distributional results for the bulk and extreme eigennvalues of matrices with Wishart distributions [32,33]. As
outlined by Johnstone [32], the principal eigenvalue of
a sample covariance matrix with a white Wishart distribution, where white implies that  = I, tends to a
distribution described by a Tracy-Widom law of order 1
[34]. Specifically, if n, p → ∞, n/p → η ≥ 1, then the
distribution of the rescaled principal eigenvalue:
λ1 − μ( p, n)
σ ( p, n)

twi =

where rX̃ is the rank of X̃, λi is the
eigenvalue of S and
the variance of the ith PC of X̃, vi is the ith eigenvector of S
and the loadings for the ith PC of X̃ and X̃vi is the ith PC.
It is assumed that the eigenvalues are sorted in decreasing
ith

(4)

tends to a Tracy-Widom law of order 1, where μ(p, n) =
√
√
1/3
√
√ 
( n−1+ p)2
n−1+ p
√1
√1
and
σ
(
p,
n)
=
+
.
n
n
p
n−1
For p > n, the Tracy-Widom distribution still holds
with p and n simply reversed in the μ( p, n) and σ ( p, n)
parameter definitions. Although an asymptotic result, this
distribution was found to hold well even for p and n values as small as p = 20 and n = 5 [32]. It also holds well
even when the underlying distribution of the elements of
X̃ is not normal [35].
In cases where  has q variances greater than 1, i.e.,
a spiked covariance model, Johnstone [32] demonstrated
that this distribution approximates the distribution of the
(q + 1)th eigenvalue but with slightly heavier tails. This
result can therefore be used to compute a conservative statistical significance for all of the PCs of X̃ based on the
associated eigenvalues under a null hypothesis of uncorrelated MVN data (e.g., use of PCA for population genetics
[36]). Specifically, the statistical significance of PC i can be
determined by first computing a Tracy-Widom distributed
statistic, twi , for the eigenvalue, λi , associated with the PC
using equation 4:

(2)

i=1

(3)

λi − μ(p − i + 1, n)
σ (p − i + 1, n)

(5)

Under the H0 that the data is a sample from a MVN
distribution with no pair-wise correlation among the individual variables, the p-value for PC i is then computed as

Frost et al. BMC Bioinformatics (2015) 16:70

Page 4 of 11

the probability of a Tracy-Widom law of order 1 statistic
more extreme than twi :
p-valuePCi = 1 − FTW (twi )

(6)

where FTW () is the cumulative distribution function of a
Tracy-Widom law of order 1 random variable. This probability can be computed using either numerical lookup
tables such as those supported by the RMTstat R package
or via the Gamma approximation to the Tracy-Widom distribution detailed in Chiani [37]. The SGSE method currently uses the Gamma approximation for more accurate
coverage of the tails of the distribution.
Number of PCs used to represent data

The SGSE method supports three options for determining
q, the number of PCs used to represent the spectra of X:
1. All PCs with non-zero variance:
q = maxi λi > 0 = rX̃
2. All statistically significant PCs at a specific α level
where statistical significance of a given PC i is
determined according (6).
3. A specified number, q∗ , with the constraint that q∗
cannot be greater than the number of PCs with nonzero variance: q = q∗ , s.t. q∗ ≤ rX̃ . If specified, q∗ will
typically be set to a small number, e.g., 1 or 2, to
minimize computational cost of the SGSE algorithm.
PCGSE for SGSE

Our PCGSE method [27] is used to compute the statistical
significance of the association between each of the f gene
sets defined in A and each of the first q PCs of X̃ where
q is determined using one of the three methods detailed
in Section “Number of PCs used to represent data” above.
Let the p-value computed via PCGSE for PC i and gene set
j be represented using the notation p-valuePCi ,gsj .
Although any supported PCGSE options can be used
with SGSE, by default, the SGSE method executes PCGSE
using the Fisher-transformed Pearson correlation coefficient between each variable and each PC as the gene-level
test statistic and the correlation-adjusted standardized
mean difference statistic as the gene set test statistic with
statistical significance of the gene set test statistic under
a competitive H0 computed using a two-sided t-test as
detailed in Frost et al. [27].
Combined significance of PCGSE p-values

For each of the f gene sets, the p-values computed via
PCGSE for the q selected PCs of X̃ are combined using
the weighted Z-method, a generalization of the untransformed Z-transform test [38,39]. The weighted Z-method
combines Z-statistics generated for each of multiple independent p-values using weights specific to each p-value.
This approach for combining p-values is justified for SGSE

under the assumption of multivariate normality for x making both the uncorrelated PCs of X̃, and the p-values generated by PCGSE with respect to those PCs, independent.
If x is significantly non-Gaussian, then the PC-specific
p-values will be dependent and techniques such as Kost’s
method [40] or a generalized version of Fisher’s method
[41] must be employed instead of the weighted Z-method.
In the context of SGSE, a weighed Z-statistic is generated
for each of the f gene sets as follows:


q
−1 1 − p-value
PCi ,gsj
i=1 wi 
(7)
Zgsj =

q
2
w
i=1 i
where wi is a weight specific to PC i of X̃ and −1 () is the
inverse standard normal CDF. Two options are supported
for determining the PC-specific weights, wi :
1. The weight is set to the variance of each PC: wi = λi
2. The weight is set to the variance of each PC scaled by
the lower-tailed p-value computed for the PC
variance according to the Tracy-Widom distribution
as detailed in Section “PC statistical significance”:
wi = (1 − p-valuePCi )λi = FTW (twi )λi
The overall p-value representing the statistical significance of the association between gene set j and the spectra
of X is then computed using a one-sided z-test on Zgsi :


(8)
p-valuegsj = 1 −  Zgsj
SGSE evaluation
Benchmark cluster-based gene set testing method

To support comparative evaluation of the SGSE method,
we implemented a cluster-based gene set testing method
that is representative of a large number of existing cluster and network-based gene set testing methods. Our
benchmark cluster-based method computes the statistical significance of the association between gene sets and a
data set as follows:
1. Cluster the p genomic variables in X̃ using k-means
clustering with the Hartigan and Wong algorithm
[42], 5 restarts and k set according to the global
maximum of the gap statistic [19] as computed using
the clusGap() function in the cluster R package [43]
with the number of bootstrap resamples defaulting to
100.
2. Compute the statistical significance of the
association between each of the f gene sets defined in
A and the k-means clustering using Pearson’s χ 2 test
of independence on a 2 × k contingency table whose
first row holds the counts of gene set members in
each of the k clusters and whose second row holds
the total size of each of the k clusters.
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Evaluation using simulated gene sets and simulated data

To explore the type I and type II error rates for the
SGSE method and benchmark cluster-based method, a
set of simulation studies were performed. In each simulation study, the SGSE method, using both choices for PC
weights, and the cluster-based method were used to compute the statistical association between 10 disjoint gene
sets, each of size 20, and the spectra of 1000 simulated
gene expression datasets each comprised by 50 independent observations of a 200 dimension random vector simulated according to a multivariate normal distribution, ∼
MVN(0, ). The structure of  varied between the simulation studies as follows:
1. Test of type I error rate:  = I, reflecting a true H0 .
2. Test of power using single factor design: In this case,
 was generated as a single factor model with
 = λ1 α 1 α T1 + λd I, where λ1 = 4, λd = 1 and α 1 is a
200-dimensional vector with all elements√equal to 0
except for the first 20 which were set to .05. This
population covariance design represents a true
association between the first gene set and the first PC.
3. Test of power using two factor design: In this case, 
was generated as a two-factor model with
 = λ1 α 1 α T1 + λ2 α 2 α 2 T + λd I, where λ1 = 4, λ2 =
3, λd = 1, α 1 is a 200-dimensional vector with all
elements
√ equal to 0 except for the first 10 which were
set to .1 and α 2 is a 200-dimensional vector with all
elements equal
√ to 0 except for the second 10 which
were set to .1 . This population covariance design
represents a true association between the first gene
set and the first and second PCs with half of the gene
set associated with PC 1 and half associated with
PC 2.
For all three simulation studies, the SGSE method was
executed on the 1000 simulated datasets using default
settings for PCGSE, as specified in Section “PCGSE
for SGSE”, and both weighting methods outlined in
Section “Combined significance of PCGSE p-values”. For
both the single factor and two-factor simulation designs,
the gap statistic method failed to predict any cluster structure, i.e., only a single cluster was predicted. To overcome
this issue and prevent a 0 power result for the clusterbased method, the number of clusters used with the
benchmark cluster-based method was fixed at k=2 for all
simulation cases.
Evaluation using MSigDB C2 v4.0 gene sets and Armstrong
et al. leukemia gene expression data

The SGSE method and the benchmark cluster-based
method were used to compute the statistical association
between the MSigDB C2 v4.0 gene sets and the spectra of the leukemia gene expression data [44] used in the
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2005 GSEA paper [9]. The MSigDB C2 v4.0 gene sets
and collapsed leukemia gene expression data were both
downloaded from the MSigDB repository. With a minimum gene set size of 15 and maximum gene set size of
200, 3,076 gene sets out of the original 4,722 were used
in the analysis. The SGSE method was executed on the
leukemia gene expression data using all PCs with non-zero
eigenvalues, PCGSE was called with default settings as
specified in Section “PCGSE for SGSE”, and both weighting methods outlined in Section “Combined significance
of PCGSE p-values” were employed. The benchmark
cluster-based enrichment method was executed as outlined in Section “Benchmark cluster-based gene set
testing method” (k=10 was selected as optimal by the gap
statistic test). The enrichment of the MSigDB C2 gene sets
was also computed relative to the acute myeloid leukemia
(AML) versus acute lymphoblastic leukemia (ALL)
phenotype using the competitive enrichment method
CAMERA [12] with default settings. To quantify how
well SGSE and the benchmark cluster-based method were
able to capture the known strong association between
AML/ALL status and the second PC in the data (see
analysis in Frost et al. [27]), the Spearman correlation
coefficient was calculated between unsupervised enrichment p-values and phenotype enrichment p-values for
all MSigDB C2 gene sets. For gene sets with phenotype enrichment p-values less than 0.05, contingency table
statistics were also computed measuring how well SGSE
and the cluster-based enrichment method were able to
identify MSigDB C2 gene sets significantly associated with
the AML/ALL phenotype.
Evaluation using Rosenwald et al. DLBCL gene expression
data and MSigDB C2 v4.0 gene sets

The SGSE method and the benchmark cluster-based
method were also used to compute the statistical association between the MSigDB C2 v4.0 gene sets and the
spectra of the Rosenwald et al. [45] diffuse large B-cell lymphoma (DLBCL) gene expression data. The Rosenwald
et al. data set consists of gene expression measurements
for 240 patients with DLBCL made using the Lymphochip
microarray on 7,399 genes. Microarray data and clinical covariates from the Rosenwald et al. study were both
downloaded from the paper’s supplemental information
web site. To support spectral and phenotype enrichment
analysis, the subset of the MSigDB C2 v4.0 gene sets
whose members were measured in the Rosenwald et al.
data was generated by mapping each of the Lymphochip
probes, via Genbank accession numbers, to Entrez gene
identifiers and MSigDB C2 v4.0 gene sets. Prior to execution of SGSE and the benchmark cluster-based method, all
censored subjects were removed and missing values in the
Rosenwald et al. data were imputed using k-nearest neighbor imputation using the impute.knn() function from the
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R impute package with default settings [46]. With a minimum gene set size of 15 and maximum gene set size
of 200, 3,106 gene sets out of the original 4,722 were
used in the analysis. The SGSE method was executed
on the DLBCL gene expression data using all PCs with
non-zero eigenvalues, PCGSE was called with default settings as specified in Section “PCGSE for SGSE”, and
both weighting methods outlined in Section “Combined
significance of PCGSE p-values” were employed. The
benchmark cluster-based enrichment method was executed as outlined in Section “Benchmark cluster-based
gene set testing method” (k=10 was selected as optimal by
the gap statistic test). The enrichment of the MSigDB C2
gene sets was also computed relative to the log of survival
time with the competitive enrichment method CAMERA
[12] using, as a gene-level test statistic, the z-transformed
t-statistic associated with the estimated coefficient from
a linear model between gene expression and log survival
time. To quantify how well SGSE and the benchmark
cluster-based method were able to capture the association between gene set expression and survival time, the
Spearman correlation coefficient was computed between
unsupervised enrichment p-values and phenotype enrichment p-values for all MSigDB C2 gene sets. For gene sets
with phenotype enrichment p-values less than 0.05, contingency table statistics were computed measuring how
well SGSE and the cluster-based enrichment method were
able to identify MSigDB C2 gene sets significantly associated with log survival time.

Results and discussion
Simulation example

The three simulation studies detailed in Section “Evaluation
using simulated gene sets and simulated data” were used
to evaluate the type I and type II error rates for the
SGSE method (using both weighting options) and the
benchmark cluster-based approach. Figure 1 illustrates
the results for all three simulation models.
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Single-factor power simulation

According to the population covariance matrix used in
the single-factor simulation study, only the first gene set
should be significantly associated with the first PC. As
seen in the Figure 1, plot d), this association is easily
detected via the PCGSE method. At an α = 0.05 level, the
empirical power to detect the association between the first
gene set and the spectra of the simulated data for SGSE
with variance weights was 0.15, for SGSE with TracyWidom scaled variance weights the empirical power was
0.95 and for the cluster-based method the empirical power
was 0.92. These results demonstrate that the power of the
SGSE method to detect an association in the single factor case is strongly dependent on the choice of weights
used to combine the PCGSE-generated p-values in the
weighted Z-method, as detailed in Section “Combined
significance of PCGSE p-values”. The impact of PCGSE
p-value weights for the simulation example can be seen
in Figure 1 plots b), e) and h). These plots show both the
PC variance weights for the simulated datasets as well as
weights calculated by scaling the PC variance using the
lower-tailed p-value computed using the Tracy-Widom
distribution for the PC variance. This scaled PC variance
weighting results in weights being very close to the standard PC variance weights if the PC variance is highly
significant according to the distribution of the principal
eigenvalue of a matrix with a white Wishart distribution.
As the PC variance becomes less significant, the scaling coefficient decreases lowering the effective weight for
the PCGSE-computed p-value associated with that PC.
Although the cluster-based method had nearly the same
power as the SGSE method with Tracy-Widom scaled
variance weights, it is important to note that the gap
statistic only identified a single cluster in the data in this
case, making the cluster-based χ 2 test for gene set enrichment meaningless if a data-driven approach is taken to
determine the number of clusters.
Two-factor power simulation

Type I error rate simulation

Because the data was generated according to an identity
population covariance matrix, this simulation model is
consistent with the H0 of no association between any of
the gene sets and any of the sample PCs. As seen in the
quantile-quantile plot of unsupervised gene set enrichment p-values from the simulation study, Figure 1c), the
results for all three methods are consistent with this null.
At an α = 0.05 level, the type I error rate across all 1000
simulated data sets for SGSE with variance weights was
0.02, for SGSE with Tracy-Widom scaled variance weights
the type I error rate was 0.034 and for the cluster-based
method the type I error rate was 0.031. These results
demonstrate that all evaluated methods provide similar,
and slightly conservative, control of the type I error rate.

According to the population covariance matrix used in
the two-factor simulation study, the first gene set should
be significantly associated with both the first and second
PCs. As seen in the Figure 1, plot g), this association is
detected via the PCGSE method but the signal is much
less strong at the PC level than for the single-factor model.
It is only by combining the measured association across
all PCs that the SGSE method is able to obtain decent
power in such a scenario. At an α = 0.05 level, the empirical power to detect the association between the first gene
set and the spectra of the simulated data for SGSE with
variance weights was 0.31, for SGSE with Tracy-Widom
scaled variance weights the empirical power was 0.71 and
for the cluster-based method the empirical power was
0.52. These results again demonstrate that the power of
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Figure 1 Simulation results. Results for the simulation studies detailed in Section “Evaluation using simulated gene sets and simulated data”. For
all plots, error bars represent ±1SE for the mean value over all 1000 simulated datasets. a)-c) Results for the type I error simulation study based on
MVN data generated with an identity population covariance matrix. This model is consistent with H0 . d)-f) Results for the power simulation study
based on MVN data generated according to a single-factor population covariance matrix. Under this model, an association exists between the first
gene set and PC 1. g)-i) Results for the power simulation study based on MVN data generated according to a two-factor population covariance
matrix. Under this model, an association exists between the first gene set and PCs 1 and 2. a), d) and g) Mean p-values computed using the PCGSE
method for the first simulated gene set relative to the first 5 PCs. b), e) and h) Mean weights used by the SGSE method to combine the
PCGSE-computed p-values for each gene set relative to the first 5 PCs. PC variance weights are shown as round points connected by a solid line. PC
variance scaled by the lower-tailed p-value computed using the Tracy-Widom distribution for the PC variance is shown using square points
connected by a dashed line. c), f) and i) Quantile-quantile plot of the p-values computed using the SGSE method, with both PC variance weights
(Var.) or weights defined by the PC variance scaled by the lower-tailed Tracy-Widom p-value of the PC variance (TW*Var.), or the benchmark method
that uses a Chi-squared test between cluster membership and gene set membership (Chisq).

the SGSE method to detect an unsupervised association
is strongly dependent on the choice of weights used to
combine the PCGSE-generated p-values in the weighted
Z-method. The lower power achieved by the cluster-based
method relative to the SGSE method is also noteworthy
and is due, in this case, to the fact that portions of the
first gene set are associated with both the first and second latent factors. This population covariance design has
the effect of generating two separate correlated blocks of
variables for the members of this gene set and variable
clustering will therefore tend to separate them into distinct clusters, muting the ability of a χ 2 test to identify

an association between cluster membership and gene set
membership. Similar to the single-factor simulation, the
gap statistic failed to identify more than a single cluster in
the datasets simulated according to the two-factor model.
Leukemia gene expression example

The Armstrong et al. [44] leukemia gene expression
dataset and MSigDB C2 v4.0 gene sets were selected for
SGSE analysis because of the known association between
AML/ALL status and the spectra of the gene expression
data, as illustrated in Frost et al. [27], the easy accessibility of the data and gene sets from the MSigDB repository
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and the common use of both the gene expression data and
curated gene sets in the gene set enrichment literature
(e.g., Subramanian et al. [9]).
Figure 2 shows the association between phenotype and
unsupervised gene set enrichment p-values computed
using both the benchmark cluster-based method and the
SGSE method for the MSigDB C2 v4.0 gene sets, the
AML versus ALL phenotype and the Armstrong et al.
leukemia gene expression data. Although the true unsupervised enrichment status of the MSigDB C2 v4.0 gene
sets relative to the variance structure of the Armstrong
et al. [44] gene expression data is unknown, the phenotype enrichment results can be used as a proxy for
the true unsupervised gene set enrichment based on
the strong association between PC 2 and AML versus
ALL status [27] as well as the recent finding by Gorlov
et al. [47] that the genes with a large expression variance
among cancer cases have a very high likelihood of having a known role in tumor-genesis. As indicated by the
correlation between phenotype enrichment and unsupervised gene set enrichment p-values, the SGSE method was
able to capture a greater proportion of the AML versus
ALL enrichment signal than the benchmark cluster-based
method, irrespective of the method used to weight the
PC-specific gene set enrichment p-values, with the best
performance obtained when PC statistical significance
was used to compute the SGSE weights. The benefits of
the SGSE method relative to cluster-based enrichment
are most clearly visible when considering identification of
AML/ALL-associated gene sets via unsupervised enrichment using a phenotype enrichment threshold of α = 0.1.
In this case, anti-conservative nature of the χ 2 test used in
the cluster-based method leads to a high type I error rate
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and a very low positive predictive value (PPV) of 0.14 as
displayed in plot (a), whereas the SGSE method has a PPV
0.39 when using PC variance weights as displayed in plot
(b) and a PPV of 0.53 when using as weights the PC variance scaled by the lower-tailed Tracy-Widom p-value for
the variance as shown in plot (c).
The χ 2 test is anti-conservative in this case because it
assumes the contingency table is populated via random
sampling from a common distribution. In this case, however, the contingency table is populated using genomic
variables whose values are not in fact independent. Thus,
the χ 2 test is using a grossly inflated sample size. Similar issues plague other uses of gene sampling in gene set
testing, see Goeman et al. [30] for a discussion. Additional
file 1 contains the top ten gene sets returned by each of
these methods for the Armstrong et al. gene expression
data. These lists clearly highlight the performance difference between SGSE and the cluster-based χ 2 test. While
SGSE returns a set of cancer related gene sets in the top
ten results, the χ 2 test returns gene sets without a clear
cancer relationship and with very extreme p-values.
SGSE analysis of the MSigDB C2 v4.0 gene sets and
Armstrong et al. [44] leukemia gene expression data
illustrates the biological motivation for spectral gene set
enrichment, shows the clear superiority of the SGSE
approach relative to standard cluster-based gene set tests
and demonstrates the importance of PC-specific p-value
weights that take into account the statistical significance
of each PC.
DLBCL gene expression example

The Rosenwald et al. [45] DLBCL gene expression dataset
is another good example of a clear association between the

Figure 2 Leukemia gene expression results. Scatter plot showing the association between phenotype gene set enrichment p-values and
unsupervised gene set enrichment p-values computed using the benchmark cluster-based method (plot a)) and SGSE (plots b) and c)) for the
Armstrong et al. [44] leukemia gene expression data, AML/ALL phenotype, and MSigDB C2 v4.0 gene sets. Phenotype enrichment, unsupervised
cluster-based enrichment and spectral gene set enrichment p-values were computed as outlined in Section “Evaluation using MSigDB C2 v4.0 gene
sets and Armstrong et al. leukemia gene expression data”. Displayed in each plot is the Spearman correlation coefficient between phenotype and
unsupervised gene set enrichment p-values and the positive predictive value of unsupervised gene set enrichment for identifying gene sets that are
significantly enriched relative to the phenotype at an α = 0.1 (shown by dotted lines). The results from the two different SGSE weighting methods
outlined in Section “Combined significance of PCGSE p-values” are shown in plots b) and c) with b) plotting SGSE p-values generated using PC
variance weighting and c) plotting SGSE p-values generated using weights defined by the PC variance scaled by the lower-tailed Tracy-Widom
p-value for the variance.
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variance structure of gene expression data and an interesting clinical phenotype, in this case log survival time.
Similar to the Armstrong et al. leukemia gene expression
data, the Rosenwald et al. DBLCL gene expression data
is easily accessible and has been widely reanalyzed in the
genomics literature, factors that will support interpretation and replication of the reported SGSE results by other
researchers.
Figure 3 shows the association between phenotype
and unsupervised gene set enrichment p-values for the
MSigDB C2 v4.0 gene sets, log survival time and the
spectra of the Rosenwald et al. DLBCL gene expression
data. Although the true enrichment status of the MSigDB
C2 v4.0 gene sets relative to the variance structure of
the Rosenwald et al. gene expression data is unknown,
the phenotype enrichment results can again be used as
a proxy for the true spectral gene set enrichment based
on association between expression variance and cancerrelated genes [47]. Although the association between
SGSE and cluster-based p-values and phenotype p-values
was lower for the Rosenwald et al. DLBCL gene expression
data than for the Armstrong et al. leukemia gene expression data, the SGSE method was still able to capture an
appreciably greater proportion of the survival time enrichment signal as compared to the benchmark cluster-based
method, irrespective of the method used to weight the
PC-specific gene set enrichment p-values. Similar to the
findings for the leukemia gene expression data, incorporating the PC statistical significance in the SGSE weights
improved the Spearman correlation between phenotype enrichment p-values and SGSE p-values for the
Rosenwald et al. data. The superior performance of the
SGSE method relative to the benchmark cluster-based
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method was again most apparent when considering identification of survival time-associated gene sets via unsupervised enrichment using just a phenotype enrichment
threshold of α = 0.1. In this case, the choice of SGSE
weighting method also had a significant impact with a
positive predictive value (PPV) of 0.079 for cluster-based
enrichment as displayed in plot (a), a PPV of 0.17 for SGSE
when using PC variance weights as displayed in plot (b)
and a PPV of 0.3 when using as weights the PC variance
scaled by the lower-tailed Tracy-Widom p-value for the
variance as shown in plot (c).
Additional file 1 contains the top ten gene sets returned
by each of these methods for the Rosenwald et al. gene
expression data. Similar to the top gene set lists for the
leukemia gene expression data set, these lists highlight
the anti-conservative nature of the χ 2 test on this dataset.
The fact that the SGSE method with Tracy-Widom scaled
variance weights was the only method to includes a gene
set directly related to DLBCL in the top ten lends further
qualitative support to the efficacy of this approach.

Conclusions
Almost universally, gene set testing is performed in a
supervised context to measure the association between
functional groups of genes and a clinical phenotype. Many
important examples exist, however, where a gene setbased interpretation of genomic data is desired in the
absence of a phenotype variable. Although techniques
have been developed for unsupervised gene set testing,
they predominantly compute enrichment relative to a
categorical variable defined by disjoint clusters of the
genomic variables. Because such cluster-based methods
often use anti-conservative contingency table-based tests

Figure 3 DLBCL gene expression results. Scatter plot showing the association between phenotype gene set enrichment p-values and
unsupervised gene set enrichment p-values computed using the benchmark cluster-based method (plot a)) and SGSE (plots b) and c)) for the
Rosenwald et al. [45] DLBCL gene expression data, log survival time phenotype, and MSigDB C2 v4.0 gene sets. Phenotype enrichment,
unsupervised cluster-based enrichment and spectral gene set enrichment p-values were computed as outlined in Section “Evaluation using
Rosenwald et al. DLBCL gene expression data and MSigDB C2 v4.0 gene sets”. Displayed in each plot is the Spearman correlation coefficient
between phenotype and unsupervised gene set enrichment p-values and the positive predictive value of unsupervised gene set enrichment for
identifying gene sets that are significantly enriched relative to the phenotype at an α = 0.1 (shown by dotted lines). The results from the two
different SGSE weighting methods outlined in Section “Combined significance of PCGSE p-values” are shown in plots b) and c) with b) plotting
SGSE p-values generated using PC variance weighting and c) plotting SGSE p-values generated using weights defined by the PC variance scaled by
the lower-tailed Tracy-Widom p-value for the variance.
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and have performance that is strongly dependent on the
clustering algorithm and number of clusters, they are
more useful for clustering evaluation than for gene setbased interpretation of genomic data. To address the lack
of effective statistical methods for unsupervised competitive gene set testing, we have developed spectral gene
set enrichment (SGSE), available in the PCGSE R package
from CRAN. The SGSE method first computes the statistical association between gene sets and principal components (PCs) using our principal component gene set
enrichment (PCGSE) method. The overall statistical association between each gene set and the spectral structure
of the data is then computed by combining the PC-level
p-values using the weighted Z-method with weights set to
the PC variance scaled by lower-tailed p-values from the
Tracy-Widom distribution of the eigenvalue associated
with each PC. On both simulated gene sets with simulated
data and on curated gene sets with real gene expression data, the SGSE method has been shown to provide
superior estimates of unsupervised gene set enrichment
relative to standard cluster-based approaches.

Availability of supporting data
The MSigDB C2 v4.0 gene sets can be downloaded from
http://www.broadinstitute.org/gsea/msigdb/collections.jsp.
The Armstrong et al. [44] leukemia gene expression
data can be downloaded from http://www.broadinstitute.
org/gsea/datasets.jsp. The Rosenwald et al. [45] DLBCL
gene expression data can be downloaded from http://
llmpp.nih.gov/DLBCL/. An implementation of the SGSE
algorithm is available in the PCGSE R package (version ≥
0.2, http://cran.r-project.org/web/packages/PCGSE/index.
html). Due to the dependency on the Bioconductor package safe, it is recommended that PCGSE be installed using
the biocLite() function. At the R prompt, enter:
source("http://bioconductor.org/biocLite.R")
biocLite("PCGSE")

Additional file
Additional file 1: Supplemental results for leukemia and DLBCL gene
expression datasets. Contains tables listing the top ten most significantly
enriched MSigDB C2 v4.0 gene sets returned by SGSE and the cluster-based
χ 2 test on the leukemia and DLBCL gene expression datasets.
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